Robert Schell is a healthcare-focused professional with a diverse background in economics and evidence-based analysis. Currently serving as an Associate at Analysis Group, Robert leverages real-world evidence studies to assess the clinical and cost effectiveness of pharmaceuticals and medical devices. Previous experience includes roles as a Graduate Student Instructor and Researcher at the University of California, Berkeley, where Robert developed predictive machine learning algorithms for opioid overdose prevention and engaged in cost-benefit analysis for various public health initiatives. Educational credentials include a PhD in Health Policy Analysis from the University of California, Berkeley, a Master's in Applied Economics from Cornell University, and a Bachelor's in Economics from Denison University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices